Tuesday, September 13, 2016

Equine Horse Calm




Generic Name: matricaria recutita, potassium phosphate, dibasic, artemisia maritima flower, phosphorus and asarum europaeum granules

Dosage Form: FOR ANIMAL USE ONLY
Equine Horse Calm

For the highly strung, stressed and anxious horse



Indications: Homeopathic remedy to soothe highly strung, stressed or anxious horses. Will not cause drowsiness.



Dosage: Sprinkle 1 capful of pilules directly into the mouth or offer on the hand. May be given every 30 minutes for up to 10 doses if necessary or 2-3 times daily as a maintenance program. 



Caution: Consult your vet if symptoms persist or worsen.



Ingredients: Chamomilla (30C) (HPUS), Kali phos (6X) (HPUS), Cina (30C) (HPUS), Phosphorus (6C) (HPUS), Asarum (6C) (HPUS)



Sucrose (inactive ingredient).



Contains no gluten,artificial flavors, colors or preservatives



All Native Remedies health products are especially formulated by experts in the field of natural health and are manufactured according to the highest pharmaceutical standards for maximum safety and effectiveness. For more information, visit us at www.petalive.com


Distributed by


Native Remedies, LLC


6531 Park of Commerce Blvd.


Suite 160


Boca Raton, FL 33487


Phone: 1.877.289.1235


International: + 1.561.999.8857


The letters HPUS indicate that the component(s) in this product is (are) officially monographed in the Homeopathic Pharmacopoeia of the United States.



Keep this and all medicines out of reach of children.












Equine Horse Calm 
chamomilla , kali phos , cina , phosphorus, asarum  granule










Product Information
Product TypeOTC ANIMAL DRUGNDC Product Code (Source)68647-188
Route of AdministrationORALDEA Schedule    




















Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
MATRICARIA RECUTITA (MATRICARIA RECUTITA)MATRICARIA RECUTITA30 [hp_C]  in 40 mg
POTASSIUM PHOSPHATE, DIBASIC (POTASSIUM CATION)POTASSIUM PHOSPHATE, DIBASIC6 [hp_X]  in 40 mg
ARTEMISIA MARITIMA FLOWER (ARTEMISIA MARITIMA FLOWER)ARTEMISIA MARITIMA FLOWER30 [hp_C]  in 40 mg
PHOSPHORUS (PHOSPHATE ION)PHOSPHORUS6 [hp_C]  in 40 mg
ASARUM EUROPAEUM (ASARUM EUROPAEUM)ASARUM EUROPAEUM6 [hp_C]  in 40 mg






Inactive Ingredients
Ingredient NameStrength
SUCROSE 


















Product Characteristics
Color    Score    
ShapeSize
FlavorImprint Code
Contains      










Packaging
#NDCPackage DescriptionMultilevel Packaging
168647-188-10200000 mg In 1 BOTTLE, GLASSNone










Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved homeopathic01/01/2010


Labeler - Feelgood Health (538418296)









Establishment
NameAddressID/FEIOperations
W Last567284153manufacture
Revised: 09/2010Feelgood Health



Efavirenz/Emtricitabine/Tenofovir


Pronunciation: EF-a-VIR-enz/EM-trye-SYE-ta-been/ten-OF-oh-vir
Generic Name: Efavirenz/Emtricitabine/Tenofovir
Brand Name: Atripla

Severe and sometimes fatal lactic acidosis (a buildup of lactic acid in the blood) and liver problems have occurred with this type of medicine. The risk may be greater in women, patients who are very overweight, or patients who have been taking nucleoside medicines (eg, emtricitabine, tenofovir) for a long time.


Tell your doctor right away if you develop symptoms of lactic acidosis (eg, unusual weakness or tiredness; unusual muscle pain; fast or difficult breathing; stomach pain with nausea and vomiting; feeling cold, especially in the arms and legs; dizziness or light-headedness; fast or irregular heartbeat). Tell your doctor right away if you develop symptoms of liver problems (eg, yellowing of the skin or eyes, dark urine, pale stools, persistent loss of appetite, nausea, stomach pain).


Efavirenz/Emtricitabine/Tenofovir is not approved to treat hepatitis B virus (HBV) infection. Safety and effectiveness have not been confirmed in patients who both HIV and HBV. Some patients with HBV who were treated with similar medicines have had severe worsening of liver problems after they stopped treatment. Patients with both HIV and HBV who take Efavirenz/Emtricitabine/Tenofovir should have medical exams and liver function tests performed for at least several months after they stop taking Efavirenz/Emtricitabine/Tenofovir.





Efavirenz/Emtricitabine/Tenofovir is used for:

Treating HIV infection alone or along with other medicines.


Efavirenz/Emtricitabine/Tenofovir is an antiviral combination of 3 reverse transcriptase inhibitors. It works by slowing the growth of HIV, the virus that causes AIDS. Efavirenz/Emtricitabine/Tenofovir is not a cure for HIV or AIDS.


Do NOT use Efavirenz/Emtricitabine/Tenofovir if:


  • you are allergic to any ingredient in Efavirenz/Emtricitabine/Tenofovir

  • you have developed red, swollen, blistered, or peeling skin after taking efavirenz, a component of Efavirenz/Emtricitabine/Tenofovir

  • you have moderate to severe kidney problems

  • you have moderate to severe liver problems or lactic acidosis

  • you are taking adefovir, astemizole, atazanavir, bepridil, cabazitaxel, cisapride, an ergot derivative (eg, dihydroergotamine, ergotamine), ixabepilone, lurasidone, midazolam, nevirapine, pimozide, St. John's wort, terfenadine, ticagrelor, triazolam, vandetanib, or voriconazole

  • you are taking a medicine that contains lamivudine, or another medicine that contains efavirenz, emtricitabine, or tenofovir

  • you take a medicine that may harm your kidneys (eg, an aminoglycoside antibiotic [eg, gentamicin], amphotericin B, cyclosporine, a nonsteroidal anti-inflammatory drug [NSAID] [eg, ibuprofen], tacrolimus, vancomycin). Ask your doctor if you are not sure if any of your medicines might harm your kidneys

Contact your doctor or health care provider right away if any of these apply to you.



Before using Efavirenz/Emtricitabine/Tenofovir:


Some medical conditions may interact with Efavirenz/Emtricitabine/Tenofovir. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have a history of bone problems (eg, fracture, osteoporosis), seizures, diabetes, high cholesterol, kidney problems (including dialysis treatment), lactic acidosis, or liver problems (eg, hepatitis, abnormal liver function tests)

  • if you have a history of mental or mood problems (eg, depression), suicidal thoughts or actions, or alcohol or other substance abuse or dependence

  • if you are very overweight

Some MEDICINES MAY INTERACT with Efavirenz/Emtricitabine/Tenofovir. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Astemizole, bepridil, cisapride, ergot derivatives (eg, dihydroergotamine, ergotamine), midazolam, pimozide, terfenadine, or triazolam because the risk of irregular heartbeat, severe drowsiness, or breathing problems may be increased

  • Adefovir or other medicines that may harm the kidneys (eg, aminoglycoside antibiotics [eg, gentamicin], amphotericin B, cyclosporine, NSAIDs [eg, ibuprofen], tacrolimus, vancomycin) because they may increase the risk of Efavirenz/Emtricitabine/Tenofovir's side effects. Ask your doctor or pharmacist if you are not sure if any of your medicines may harm the kidneys

  • A medicine that contains lamivudine or other medicines that contain efavirenz, emtricitabine, or tenofovir because they may increase the risk of Efavirenz/Emtricitabine/Tenofovir's side effects

  • Atazanavir because its effectiveness may be decreased by Efavirenz/Emtricitabine/Tenofovir or it may increase the risk of Efavirenz/Emtricitabine/Tenofovir's side effects

  • Nevirapine or St. John's wort because they may decrease Efavirenz/Emtricitabine/Tenofovir's effectiveness

  • Cabazitaxel, ixabepilone, lurasidone, ticagrelor, vandetanib, or voriconazole because their effectiveness may be decreased by Efavirenz/Emtricitabine/Tenofovir

  • Medicines that may harm the liver (eg, acetaminophen, methotrexate, ketoconazole, isoniazid, certain medicines for HIV infection) because the risk of liver side effects may be increased. Ask your doctor if you are unsure if any of your medicines might harm the liver

  • Many prescription and nonprescription medicines (eg, used for infections, HIV, hepatitis C, blood thinning, inflammation, aches and pains, high blood pressure, high cholesterol, seizures, emergency contraception, heart problems, immune system suppression, birth control, mental or mood problems), multivitamin products, and herbal or dietary supplements (eg, herbal teas, coenzyme Q10, garlic, ginseng, ginkgo) may interact with Efavirenz/Emtricitabine/Tenofovir, increasing the risk of side effects or decreasing effectiveness

This may not be a complete list of all interactions that may occur. Ask your health care provider if Efavirenz/Emtricitabine/Tenofovir may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Efavirenz/Emtricitabine/Tenofovir:


Use Efavirenz/Emtricitabine/Tenofovir as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • An extra patient leaflet is available with Efavirenz/Emtricitabine/Tenofovir. Talk to your pharmacist if you have questions about this information.

  • Take Efavirenz/Emtricitabine/Tenofovir by mouth on an empty stomach at least 1 hour before or 2 hours after eating.

  • Take Efavirenz/Emtricitabine/Tenofovir with a full glass of water (8 oz/240 mL).

  • Do not take Efavirenz/Emtricitabine/Tenofovir if the seal over the bottle opening is broken or missing.

  • Continue to take Efavirenz/Emtricitabine/Tenofovir even if you feel well. Do not miss any doses.

  • Take Efavirenz/Emtricitabine/Tenofovir at the same time each day, preferably at bedtime, unless otherwise directed by your doctor.

  • Do not suddenly stop taking Efavirenz/Emtricitabine/Tenofovir without checking with your doctor. This may cause the virus to become less sensitive to this or other medicines. Also, some conditions (eg, hepatitis B) could become worse if you suddenly stop taking Efavirenz/Emtricitabine/Tenofovir.

  • If you miss a dose of Efavirenz/Emtricitabine/Tenofovir, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Efavirenz/Emtricitabine/Tenofovir.



Important safety information:


  • Efavirenz/Emtricitabine/Tenofovir may cause drowsiness, dizziness, or trouble concentrating. These effects may be worse if you take it with alcohol or certain medicines. Use Efavirenz/Emtricitabine/Tenofovir with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.

  • Check with your doctor before you drink alcohol or use medicines that may cause drowsiness (eg, sleep aids, muscle relaxers) while you are using Efavirenz/Emtricitabine/Tenofovir; it may add to their effects. Ask your pharmacist if you have questions about which medicines may cause drowsiness.

  • Efavirenz/Emtricitabine/Tenofovir may cause dizziness, drowsiness, trouble sleeping, trouble concentrating, or unusual dreams. These effects usually go away after you have taken Efavirenz/Emtricitabine/Tenofovir for about 2 to 4 weeks. Taking it at bedtime may help to decrease these effects. Check with your doctor if they continue or are severe.

  • Do NOT take more than the recommended dose, change your dose, or stop taking Efavirenz/Emtricitabine/Tenofovir without checking with your doctor. Taking more than the recommended dose may not provide additional benefits and may increase the risk of side effects.

  • You should be tested for HBV infection before you start to take Efavirenz/Emtricitabine/Tenofovir.

  • Keep a list of all the medicines that you take. Make a new list each time medicines are added or stopped. Find out about medicines that should not be taken while you are using Efavirenz/Emtricitabine/Tenofovir. Be sure that each of your health care providers knows all the medicines that you are taking.

  • Efavirenz/Emtricitabine/Tenofovir is not a cure for HIV infection. Patients may still get illnesses and infections associated with HIV. Remain under the care of your doctor.

  • Efavirenz/Emtricitabine/Tenofovir does not stop the spread of HIV to others through blood or sexual contact. Use barrier methods of birth control (eg, condoms) if you have HIV infection. Do not share needles, injection supplies, or items like toothbrushes or razors.

  • When your medicine supply is low, get more from your doctor or pharmacist as soon as you can. Do not stop taking Efavirenz/Emtricitabine/Tenofovir, even for a short period of time. If you do, the virus may grow resistant to the medicine and become harder to treat.

  • Changes in body fat (eg, an increased amount of fat in the upper back, neck, breast, and trunk, and loss of fat from the legs, arms, and face) may occur in some patients taking Efavirenz/Emtricitabine/Tenofovir. The cause and long-term effects of these changes are unknown. Discuss any concerns with your doctor.

  • Efavirenz/Emtricitabine/Tenofovir may improve immune system function. This may reveal hidden infections in some patients. Tell your doctor right away if you notice symptoms of infection (eg, fever, sore throat, weakness, cough, shortness of breath) after you start Efavirenz/Emtricitabine/Tenofovir.

  • Check with your doctor to see if you should take a calcium and vitamin D supplement while you are taking Efavirenz/Emtricitabine/Tenofovir.

  • Diabetes patients - Efavirenz/Emtricitabine/Tenofovir may affect your blood sugar. Check blood sugar levels closely. Ask your doctor before you change the dose of your diabetes medicine.

  • Women who may become pregnant should have a negative pregnancy test before they start to take Efavirenz/Emtricitabine/Tenofovir. Discuss any questions or concerns with your doctor.

  • If you may become pregnant, you must use an effective form of birth control while you take Efavirenz/Emtricitabine/Tenofovir and for 12 weeks after you stop taking it. Hormonal birth control (eg, birth control pills) may not work as well while you are using Efavirenz/Emtricitabine/Tenofovir. You should always use a barrier form of birth control (eg, condoms), even if you already use another method of birth control (eg, hormonal birth control). If you have questions about effective birth control, talk with your doctor.

  • Efavirenz/Emtricitabine/Tenofovir may affect certain lab tests, including drug tests. Be sure your doctor and lab personnel know you are taking Efavirenz/Emtricitabine/Tenofovir.

  • Lab tests, including liver and kidney function, cholesterol and triglyceride levels, and bone density, may be performed while you use Efavirenz/Emtricitabine/Tenofovir. These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.

  • Use Efavirenz/Emtricitabine/Tenofovir with caution in the ELDERLY; they may be more sensitive to its effects.

  • Efavirenz/Emtricitabine/Tenofovir should not be used in CHILDREN younger than 18 years old; safety and effectiveness in these children have not been confirmed.

  • PREGNANCY and BREAST-FEEDING: Efavirenz/Emtricitabine/Tenofovir may cause harm to the fetus. Do not become pregnant while you take Efavirenz/Emtricitabine/Tenofovir and for 12 weeks after you stop taking it. If you think you may be pregnant, contact your doctor. You will need to discuss the benefits and risks of using Efavirenz/Emtricitabine/Tenofovir while you are pregnant. It is not known if Efavirenz/Emtricitabine/Tenofovir is found in breast milk. Do not breast-feed while taking Efavirenz/Emtricitabine/Tenofovir. Mothers infected with HIV should not breast-feed. There is a risk of passing the HIV infection or Efavirenz/Emtricitabine/Tenofovir to the baby.


Possible side effects of Efavirenz/Emtricitabine/Tenofovir:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Back pain; cough; darkened skin color on the palms of hands or soles of feet; diarrhea; dizziness; drowsiness; gas or indigestion; headache; loss of appetite; mild stomach pain; muscle or joint aches; nausea; skin discoloration (small spots or freckles); stomach upset; strange dreams; stuffy or runny nose; tiredness; trouble concentrating; trouble sleeping; vomiting.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); bone pain; change in personality; chest pain; confusion; decreased coordination; delusions; fever, chills, or persistent sore throat; hallucinations; memory loss; mental, mood, or behavior changes (eg, abnormal thoughts, agitation, aggression, anxiety, depression, nervousness, paranoia); muscle pain or weakness; numbness, burning, pain, or tingling of the hands, feet, or skin; red, swollen, blistered, or peeling skin; seizures; severe or persistent stomach pain, nausea, or vomiting; shortness of breath; suicidal thoughts or actions; symptoms of kidney problems (eg, increased or decreased urination, increased thirst); symptoms of lactic acidosis (eg, dizziness or lightheadedness; fast or difficult breathing; fast or irregular heartbeat; feeling cold, especially in the arms and legs; stomach pain with nausea and vomiting; unusual muscle pain; unusual weakness or tiredness); symptoms of liver problems (eg, dark urine; pale stools; persistent loss of appetite; yellowing of the skin or eyes).



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Efavirenz/Emtricitabine/Tenofovir side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include hallucinations; muscle twitching; severe dizziness, drowsiness, or coordination problems; trouble concentrating; trouble sleeping.


Proper storage of Efavirenz/Emtricitabine/Tenofovir:

Store Efavirenz/Emtricitabine/Tenofovir at 77 degrees F (25 degrees C). Brief storage at temperatures between 59 and 86 degrees F (15 and 30 degrees C) is permitted. Store away from heat, moisture, and light. Store only in original container and keep it tightly closed. Do not store in the bathroom. Do not use Efavirenz/Emtricitabine/Tenofovir if it is past the expiration date on the bottle. Keep Efavirenz/Emtricitabine/Tenofovir out of the reach of children and away from pets.


General information:


  • If you have any questions about Efavirenz/Emtricitabine/Tenofovir, please talk with your doctor, pharmacist, or other health care provider.

  • Efavirenz/Emtricitabine/Tenofovir is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Efavirenz/Emtricitabine/Tenofovir. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Efavirenz/Emtricitabine/Tenofovir resources


  • Efavirenz/Emtricitabine/Tenofovir Side Effects (in more detail)
  • Efavirenz/Emtricitabine/Tenofovir Use in Pregnancy & Breastfeeding
  • Efavirenz/Emtricitabine/Tenofovir Drug Interactions
  • Efavirenz/Emtricitabine/Tenofovir Support Group
  • 34 Reviews for Efavirenz/Emtricitabine/Tenofovir - Add your own review/rating


  • Atripla Prescribing Information (FDA)

  • Atripla Advanced Consumer (Micromedex) - Includes Dosage Information

  • Atripla Consumer Overview



Compare Efavirenz/Emtricitabine/Tenofovir with other medications


  • HIV Infection

E-Z-Cat Dry





Dosage Form: powder, for suspension
E-Z-Cat Dry

BARIUM SULFATE FOR SUSPENSION (2% w/w After Mixing)

E-Z-Cat Dry Description


E-Z-CAT® DRY Barium Sulfate For Suspension (2% w/w After Mixing) is for oral administration. Each 100 g contains 41 g barium sulfate. Barium sulfate, due to its high molecular density, is opaque to x-rays and, therefore, acts as a positive contrast agent for radiographic studies. The active ingredient is barium sulfate and its structural formula is BaSO4. Barium sulfate occurs as a fine, white, odorless, tasteless, bulky powder which is free from grittiness. Its aqueous suspensions are neutral to litmus. It is practically insoluble in water, solutions of acids and alkalies, and organic solvents.



Inactive Ingredients:


artificial candied sugar, citric acid, ethyl vanillin, natural and artificial orange flavor, polysorbate 80, saccharin sodium, simethicone, sodium carboxymethylcellulose, sodium carrageenan, sodium citrate, sorbitol and xanthan gum.



E-Z-Cat Dry - Clinical Pharmacology


Barium sulfate, due to its high molecular density, is opaque to x-rays and, therefore, acts as a positive contrast agent for radiographic studies. Barium sulfate is biologically inert and, therefore, is not absorbed or metabolized by the body, and is eliminated unchanged from the body.



Indications and Usage for E-Z-Cat Dry


For use in Computed Tomography of the GI tract.



Contraindications


This product should not be used in patients with known gastric or intestinal perforation or hypersensitivity to barium sulfate products.



Warnings


Rarely, severe allergic reactions of an anaphylactoid nature have been reported following administration of barium sulfate contrast agents. Appropriately trained personnel and facilities should be available for emergency treatment of severe reactions and should remain available for at least 30 to 60 minutes following administration, since delayed reactions can occur.



Precautions



General:


Diagnostic procedures which involve the use of radiopaque contrast agents should be carried out under the direction of personnel with the requisite training and with a thorough knowledge of the particular procedure to be performed. A history of bronchial asthma, atopy, as evidenced by hay fever and eczema, or a previous reaction to a contrast agent, warrant special attention. Caution should be exercised with the use of radiopaque media in severely debilitated patients and in those with marked hypertension or advanced cardiac disease.


Diagnostic procedures which involve the use of radiopaque contrast agents should be carried out under the direction of personnel with the requisite training and with a thorough knowledge of the particular procedure to be performed. A history of bronchial asthma, atopy, as evidenced by hay fever and eczema, or a previous reaction to a contrast agent, warrant special attention. Caution should be exercised with the use of radiopaque media in severely debilitated patients and in those with marked hypertension or advanced cardiac disease.


Ingestion of this product is not recommended in patients with a history of food aspiration. If barium studies are required in these patients or in patients in whom integrity of the swallowing mechanism is impaired or unknown, proceed with caution. If this product is aspirated into the larynx, further administration should be immediately discontinued.



Information For Patients:


Before administration of this product patients should be instructed to:


  1. Inform their physician if they are pregnant.

  2. Inform their physician if they are allergic to any drugs or food, or if they have had any prior reactions to barium sulfate or other contrast agents used in x-ray procedures (see PRECAUTIONS - General).

  3. Inform their physician about any other medications they are currently taking.


Drug Interactions:


The presence of barium sulfate formulations in the GI tract may alter the absorption of therapeutic agents taken concomitantly. In order to minimize any potential change in absorption, the separate administration of barium sulfate from that of other agents should be considered.



Usage in Pregnancy:


Radiation is known to cause harm to the unborn fetus exposed in utero. Therefore, radiographic procedures should only be used when, in the judgement of the physician, its use is deemed essential to the welfare of the pregnant patient.



Nursing Mothers:


Barium sulfate products may be used during lactation.



Adverse Reactions


Adverse reactions, such as nausea, vomiting, diarrhea and abdominal cramping, accompanying the use of barium sulfate formulations are infrequent and usually mild. Severe reactions (approximately 1 in 1,000,000) and fatalities (approximately 1 in 10,000,000) have occurred. Procedural complications are rare, but may include aspiration pneumonitis, barium sulfate impaction, granuloma formation, intravasation, embolization and peritonitis following intestinal perforation, vasovagal and syncopal episodes, and fatalities. It is of the utmost importance to be completely prepared to treat any such occurrence.



ALLERGIC REACTIONS


Due to the increased likelihood of allergic reactions in atopic patients, it is important that a complete history of known and suspected allergies as well as allergic-like symptoms, e.g., rhinitis, bronchial asthma, eczema and urticaria, must be obtained prior to any medical procedure utilizing these products. A mild allergic reaction would most likely include generalized pruritus, erythema or urticaria (approximately 1 in 250,000). Such reactions will generally respond to an antihistamine such as 50 mg of diphenhydramine or its equivalent. In the rarer, more serious reactions (approximately 1 in 1,000,000) laryngeal edema, bronchospasm or hypotension could develop. Severe reactions which may require emergency measures are often characterized by peripheral vasodilation, hypotension, reflex tachycardia, dyspnea, agitation, confusion and cyanosis progressing to unconsciousness. Treatment should be initiated immediately with 0.3 to 0.5 mL of 1:1000 epinephrine subcutaneously. If bronchospasm predominates, 0.25 to 0.50 grams of intravenous aminophylline should be given slowly. Appropriate vasopressors might be required. Adrenocorticosteroids, even if given intravenously, exert no significant effect on the acute allergic reactions for a few hours. The administration of these agents should not be regarded as emergency measures for the treatment of allergic reactions.


Apprehensive patients may develop weakness, pallor, tinnitus, diaphoresis and bradycardia following the administration of any diagnostic agent. Such reactions are usually non-allergic in nature and are best treated by having the patient lie flat for an additional 10 to 30 minutes under observation.



Overdosage


Apprehensive patients may develop weakness, pallor, tinnitus, diaphoresis and bradycardia following the administration of any diagnostic agent. Such reactions are usually non-allergic in nature and are best treated by having the patient lie flat for an additional 10 to 30 minutes under observation.



E-Z-Cat Dry Dosage and Administration


This product should be used as directed by a physician. The volume and concentration of the CT barium sulfate suspension to be administered will depend on the degree and extent of concentration required in the area(s) under examination and on the equipment and technique employed.



Instructions for Mixing:


Add 450 mL water into a mixing container. Pour contents of the pouch into the container. Replace the cap, invert the container to mix the powder with water and shake vigorously for 20 seconds. Let mixture stand for 5 minutes. Reshake prior to use for 15 seconds.



Yield:


460 mL of a 2% w/w barium sulfate suspension.



Suggested 30 Minute Barium Administration Protocol for Abdomen Studies:


Administer 300 mL (10 fl oz) CT barium sulfate suspension 30 minutes before scan and 150 mL (5 fl oz) immediately prior to scan; or use as directed by physician.



Suggested 90 Minute Barium Administration Protocol for Abdomen / Pelvis Studies:


Administer 450 mL (15 fl oz) CT barium sulfate suspension 90 minutes before scan, another 300 mL (10 fl oz) 30 minutes before scan, and 150 mL (5 fl oz) immediately prior to scan; or use as directed by physician.



How is E-Z-Cat Dry Supplied


E-Z-CAT® DRY is supplied in the following quantities:

50 x 23 g (0.8 oz) Pouches, Cat. No. 727, NDC 32909-727-01



STORAGE


Store product to protect from excessive heat (above 40°C).


After reconstitution with water, product must be refrigerated and used within 48 hours. Discard any unused portion.



Manufactured by E-Z-EM Canada Inc.

a subsidiary of E-Z-EM, Inc.

Lake Success, NY 11042


rev. 04/11

TX1635



 


 


E-Z-Cat Dry

BARIUM SULFATE FOR SUSPENSION (2% w/w After Mixing)


NDC: 32909-727-01










E-Z-Cat Dry 
barium sulfate  powder, for suspension










Product Information
Product TypeHUMAN PRESCRIPTION DRUGNDC Product Code (Source)32909-727
Route of AdministrationORALDEA Schedule    








Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
BARIUM SULFATE (BARIUM)BARIUM SULFATE9.5 g  in 23 g


























Inactive Ingredients
Ingredient NameStrength
CARBOXYMETHYLCELLULOSE SODIUM 
ANHYDROUS CITRIC ACID 
DIMETHICONE 
ETHYL VANILLIN 
POLYSORBATE 80 
SACCHARIN SODIUM 
SILICON DIOXIDE 
TRISODIUM CITRATE DIHYDRATE 
CARRAGEENAN 
SORBITOL 
XANTHAN GUM 


















Product Characteristics
ColorWHITEScore    
ShapeSize
FlavorORANGEImprint Code
Contains      














Packaging
#NDCPackage DescriptionMultilevel Packaging
132909-727-0150  In 1 BOXcontains a POUCH
123 g In 1 POUCHThis package is contained within the BOX (32909-727-01)










Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
Unapproved drug other01/01/1996


Labeler - E-Z-EM Canada Inc (204211163)









Establishment
NameAddressID/FEIOperations
E-Z-EM Canada Inc204211163MANUFACTURE, ANALYSIS, PACK, LABEL









Establishment
NameAddressID/FEIOperations
Cimbar Performance Minerals, Inc.963805671API MANUFACTURE
Revised: 12/2011E-Z-EM Canada Inc

Ease It




Generic Name: tea tree oil, lavender oil, witch hazel, aloe vera leaf, calendula officinalis flower, vitamin a, methyl salicylate and vitamin e cream

Dosage Form: FOR ANIMAL USE ONLY
Ease It

A Topical Cream for Equines


Ease It is a formulation based on Tea Tree

Oil and Lavender oil.

Ease It IS FOR TOPICAL USE ONLY



Ease It contains :

Tea Tree Oil

Lavender Oil

Hamamelis Water

Aloe vera, Calendula Oil

Vitamin A, Methyl salicylate, Vitamin E plus excipients



FOR USE ON ANIMALS ONLY



Ease It contains NO animal parts or residues


Imported to the USA by :

Emerald Valley Natural Health Inc, Exeter, NH 03833


Batch No: 94431

Use by Date : 03/12/11


Ease It is manufactured in the UK by

SCA Nutec [Provimi Ltd]

Nutec Mill, Eastern Avenue

Lichfield, Staffordshire, WS13 7SE, UK



Exported by :

Equiglobal Ltd

Manningtree, Essex, CO11 1UT, UK


20 Litres/5.283 gallons [US]









Ease It 
tea tree oil, lavender oil, witch hazel, aloe vera leaf, calendula officinalis flower, vitamin a, methyl salicylate, and vitamin e  cream










Product Information
Product TypePRESCRIPTION ANIMAL DRUGNDC Product Code (Source)52338-744
Route of AdministrationTOPICALDEA Schedule    





























Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
TEA TREE OIL (TEA TREE OIL)TEA TREE OIL10 mg  in 1 mL
LAVENDER OIL (LAVENDER OIL)LAVENDER OIL5 mg  in 1 mL
WITCH HAZEL (WITCH HAZEL)WITCH HAZEL10 mg  in 1 mL
ALOE VERA LEAF (ALOE VERA LEAF)ALOE VERA LEAF15 mg  in 1 mL
CALENDULA OFFICINALIS FLOWER (CALENDULA OFFICINALIS FLOWER)CALENDULA OFFICINALIS FLOWER5 mg  in 1 mL
VITAMIN A (VITAMIN A)VITAMIN A1000 [iU]  in 1 mL
METHYL SALICYLATE (METHYL SALICYLATE)METHYL SALICYLATE10 mg  in 1 mL
VITAMIN E (VITAMIN E)VITAMIN E4650 mg  in 1 mL





Inactive Ingredients
Ingredient NameStrength
No Inactive Ingredients Found


















Product Characteristics
Color    Score    
ShapeSize
FlavorImprint Code
Contains      










Packaging
#NDCPackage DescriptionMultilevel Packaging
152338-744-2020000 mL In 1 BOTTLENone










Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other04/01/2010


Labeler - SCA NuTec (233072193)









Establishment
NameAddressID/FEIOperations
SCA NuTec233072193manufacture
Revised: 04/2010SCA NuTec



Ectosone Mild-Lotion



Generic Name: betamethasone valerate (Topical application route)


bay-ta-METH-a-sone VAL-er-ate


Commonly used brand name(s)

In the U.S.


  • Betamethacot

  • Beta-Val

  • Luxiq

  • Qualisone

  • Valisone

In Canada


  • Betacort Scalp Lotion

  • Betnovate

  • Betnovate-1/2

  • Celestoderm-V

  • Celestoderm-V/2

  • Ectosone Mild-Lotion

  • Ectosone Regular-Cream

  • Ectosone Regular-Lotion

  • Ectosone Scalp Lotion

  • Metaderm Mild

  • Metaderm Regular

  • Novo-Betamet

Available Dosage Forms:


  • Gel/Jelly

  • Ointment

  • Lotion

  • Cream

  • Foam

Therapeutic Class: Corticosteroid, Intermediate


Pharmacologic Class: Betamethasone


Uses For Ectosone Mild-Lotion


Betamethasone topical is used to help relieve redness, itching, swelling, or other discomfort caused by skin conditions. Betamethasone foam is used for scalp problems. This medicine is a corticosteroid (cortisone-like medicine or steroid).


This medicine is available only with your doctor's prescription.


Before Using Ectosone Mild-Lotion


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of betamethasone topical in the pediatric population. However, because of this medicine's toxicity, it should be used with caution. Children may absorb large amounts through the skin, which can cause serious side effects. If your child is using this medicine, follow your doctor's instructions very carefully. For the foam form, safety and efficacy have not been established.


Geriatric


No information is available on the relationship of age to the effects of betamethasone topical in geriatric patients.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.


Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.


Other Medical Problems


The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:


  • Cushing's syndrome (adrenal gland disorder) or

  • Diabetes or

  • Hyperglycemia (high blood sugar) or

  • Intracranial hypertension (increased pressure in the head)—Use with caution. May make these conditions worse.

  • Infection of the skin at or near the place of application or

  • Large sores, broken skin, or severe skin injury at the place of application—The chance of side effects may be increased.

Proper Use of betamethasone

This section provides information on the proper use of a number of products that contain betamethasone. It may not be specific to Ectosone Mild-Lotion. Please read with care.


It is very important that you use this medicine only as directed by your doctor. Do not use more of it, do not use it more often, and do not use it for a longer time than your doctor ordered. To do so may cause unwanted side effects or skin irritation.


This medicine is for use on the skin only. Do not get it in your eyes. Do not use it on skin areas that have cuts, scrapes, or burns. If it does get on these areas, rinse it off right away with water.


This medicine should only be used for skin conditions that your doctor is treating. Check with your doctor before using it for other conditions, especially if you think that an infection may be present. This medicine should not be used to treat certain kinds of skin infections or conditions, such as severe burns.


To use cream, lotion, or ointment:


  • Wash your hands with soap and water before and after using this medicine.

  • Apply a thin layer of this medicine to the affected area of the skin. Rub it in gently.

  • With the lotion, protect the skin from water, clothing, or anything that causes rubbing until the medicine has dried. Also, shake the lotion well before using it.

  • Do not bandage or otherwise wrap the skin being treated unless directed to do so by your doctor.

  • If the medicine is applied to the diaper area of an infant, do not use tight-fitting diapers or plastic pants unless directed to do so by your doctor.

  • If your doctor ordered an occlusive dressing or airtight covering to be applied over the medicine, make sure you know how to apply it. Occlusive dressings increase the amount of medicine absorbed through your skin, so use them only as directed. If you have any questions about this, check with your doctor.

To use the foam:


  • This medicine comes with a patient information insert. Read and follow the instructions carefully.

  • Wash your hands with soap and water before and after using this medicine.

  • Turn the can upside down and place a small amount of medicine in a saucer or any cool, clean surface. Do not put the foam directly in your hands. This will melt the foam immediately upon contact with warm skin.

  • Move the hair away and put a small amount of the foam on the affected areas of the scalp. Massage it in gently until the medicine has dried.

  • Do not wash or rinse the treated areas immediately after applying the medicine.

  • Do not use this medicine near heat, open flame, or while smoking.

Dosing


The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.


The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.


  • For redness, itching, and swelling of the skin:
    • For topical dosage forms (cream and ointment):
      • Adults—Apply to the affected area of the skin one to three times per day.

      • Children—Use and dose must be determined by your doctor.


    • For topical dosage form (lotion):
      • Adults—Apply a few drops to the affected area of the skin two times per day (morning and evening).

      • Children—Use and dose must be determined by your doctor.



  • For scalp problems:
    • For topical dosage form (foam):
      • Adults—Apply to the affected area of the scalp two times per day (once in the morning and once at night).

      • Children—Use and dose must be determined by your doctor.



Missed Dose


If you miss a dose of this medicine, apply it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule.


Storage


Keep out of the reach of children.


Do not keep outdated medicine or medicine no longer needed.


Ask your healthcare professional how you should dispose of any medicine you do not use.


Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.


Store the can of the foam at room temperature, away from heat and direct light. Do not freeze. Do not keep this medicine inside a car where it could be exposed to extreme heat or cold. Do not poke holes in the canister or throw it into a fire, even if the canister is empty.


Precautions While Using Ectosone Mild-Lotion


It is very important that your doctor check the progress of you or your child at regular visits for any unwanted effects that may be caused by this medicine.


If your or your child's symptoms do not improve within a few days, or if they become worse, check with your doctor.


Using too much of this medicine or using it for a long time may increase your risk of having adrenal gland problems. The risk is greater for children and patients who use large amounts for a long time. Talk to your doctor if you or your child have more than one of these symptoms while you are using this medicine: blurred vision; dizziness or fainting; a fast, irregular, or pounding heartbeat; increased thirst or urination; irritability; or unusual tiredness or weakness.


Stop using this medicine and check with your doctor right away if you or your child have a skin rash, burning, stinging, swelling, or irritation on the skin.


Do not use cosmetics or other skin care products on the treated areas.


Ectosone Mild-Lotion Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor immediately if any of the following side effects occur:


More common
  • Burning, itching, or stinging at the application site

Less common
  • Hair loss

  • thinning of the hair

Incidence not known
  • Blistering, burning, crusting, dryness, or flaking of the skin

  • irritation

  • itching, scaling, severe redness, soreness, or swelling of the skin

  • redness and scaling around the mouth

  • thinning of the skin with easy bruising, especially when used on where the skin folds together (e.g. between the fingers)

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


Less common
  • Acne or pimples

  • burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings

Incidence not known
  • Burning and itching of the skin with pinhead-sized red blisters

  • burning, itching, and pain in hairy areas, or pus at the root of the hair

  • increased hair growth on the forehead, back, arms, and legs

  • lightening of normal skin color

  • lightening of treated areas of dark skin

  • reddish purple lines on the arms, face, legs, trunk, or groin

  • softening of the skin

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More Ectosone Mild-Lotion resources


  • Ectosone Mild-Lotion Use in Pregnancy & Breastfeeding
  • Ectosone Mild-Lotion Drug Interactions
  • Ectosone Mild-Lotion Support Group
  • 13 Reviews for Ectosone-Lotion - Add your own review/rating


Compare Ectosone Mild-Lotion with other medications


  • Atopic Dermatitis
  • Dermatitis
  • Dermatological Disorders
  • Lichen Planus
  • Lichen Sclerosus

esmolol Intravenous


ES-moe-lol


Commonly used brand name(s)

In the U.S.


  • Brevibloc

  • Esmolol HCl

Available Dosage Forms:


  • Solution

Therapeutic Class: Cardiovascular Agent


Pharmacologic Class: Beta-Adrenergic Blocker, Cardioselective


Uses For esmolol


Esmolol is used to control rapid heartbeats or abnormal heart rhythms. esmolol is also used to treat fast heartbeat and high blood pressure during surgery, after surgery, or during other medical procedures .


esmolol is a beta-blocker. It works by affecting the response to nerve impulses in certain parts of the body, like the heart. As a result, the heart beats slower and decreases the blood pressure. When the blood pressure is lowered, the amount of blood and oxygen is increased to the heart .


esmolol is available only with your doctor's prescription .


Before Using esmolol


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For esmolol, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to esmolol or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Appropriate studies have not been performed on the relationship of age to the effects of esmolol in the pediatric population. Safety and efficacy have not been established .


Geriatric


No information is available on the relationship of age to the effects of esmolol in geriatric patients. However, elderly patients are more likely to have age-related kidney problems, which may require an adjustment in the dose for patients receiving esmolol .


Pregnancy








Pregnancy CategoryExplanation
All TrimestersCAnimal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women.

Breast Feeding


There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are receiving esmolol, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.


Using esmolol with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Albuterol

  • Amiodarone

  • Arformoterol

  • Bambuterol

  • Bitolterol

  • Broxaterol

  • Clenbuterol

  • Clonidine

  • Colterol

  • Diltiazem

  • Dronedarone

  • Fenoldopam

  • Fenoterol

  • Formoterol

  • Hexoprenaline

  • Indacaterol

  • Isoetharine

  • Levalbuterol

  • Metaproterenol

  • Pirbuterol

  • Procaterol

  • Reproterol

  • Rimiterol

  • Ritodrine

  • Salmeterol

  • Terbutaline

  • Tretoquinol

  • Tulobuterol

  • Verapamil

Using esmolol with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Acarbose

  • Aceclofenac

  • Acemetacin

  • Acetohexamide

  • Alclofenac

  • Alfuzosin

  • Amlodipine

  • Apazone

  • Arbutamine

  • Benfluorex

  • Benoxaprofen

  • Bromfenac

  • Bufexamac

  • Bunazosin

  • Carprofen

  • Chlorpropamide

  • Clometacin

  • Clonixin

  • Dexketoprofen

  • Diclofenac

  • Diflunisal

  • Digoxin

  • Dipyrone

  • Doxazosin

  • Droxicam

  • Etodolac

  • Etofenamate

  • Felbinac

  • Felodipine

  • Fenbufen

  • Fenoprofen

  • Fentiazac

  • Floctafenine

  • Flufenamic Acid

  • Flurbiprofen

  • Gliclazide

  • Glimepiride

  • Glipizide

  • Gliquidone

  • Glyburide

  • Guar Gum

  • Ibuprofen

  • Indomethacin

  • Indoprofen

  • Insulin

  • Insulin Aspart, Recombinant

  • Insulin Glulisine

  • Insulin Lispro, Recombinant

  • Isoxicam

  • Ketoprofen

  • Ketorolac

  • Lacidipine

  • Lercanidipine

  • Lornoxicam

  • Manidipine

  • Meclofenamate

  • Mefenamic Acid

  • Meloxicam

  • Metformin

  • Mibefradil

  • Miglitol

  • Morphine

  • Morphine Sulfate Liposome

  • Moxisylyte

  • Nabumetone

  • Naproxen

  • Nicardipine

  • Nifedipine

  • Niflumic Acid

  • Nilvadipine

  • Nimesulide

  • Nimodipine

  • Nisoldipine

  • Nitrendipine

  • Oxaprozin

  • Oxyphenbutazone

  • Phenoxybenzamine

  • Phentolamine

  • Phenylbutazone

  • Pirazolac

  • Piroxicam

  • Pirprofen

  • Pranidipine

  • Prazosin

  • Propyphenazone

  • Proquazone

  • Repaglinide

  • St John's Wort

  • Sulindac

  • Suprofen

  • Tamsulosin

  • Tenidap

  • Tenoxicam

  • Terazosin

  • Tiaprofenic Acid

  • Tolazamide

  • Tolbutamide

  • Tolmetin

  • Trimazosin

  • Troglitazone

  • Urapidil

  • Zomepirac

Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.


Other Medical Problems


The presence of other medical problems may affect the use of esmolol. Make sure you tell your doctor if you have any other medical problems, especially:


  • Bradycardia (slow heartbeat) or

  • Heart block or

  • Heart failure—Should not use in patients with these conditions .

  • Diabetes or

  • Hypoglycemia (low blood sugar)—May cover up some of the signs and symptoms of these diseases, such as a fast heartbeat .

  • Hypotension (low blood pressure)—May worsen this condition .

  • Kidney disease—Use with caution. The effects may be increased because of slower removal from the body .

  • Lung disease (e.g. asthma, bronchitis, emphysema)—May cause difficulty with breathing in patients with this condition .

Proper Use of esmolol


A nurse or other trained health professional will give you esmolol. esmolol is given through a needle placed into one of your veins .


Precautions While Using esmolol


Your doctor will only give you a few doses of esmolol until your condition improves, and then you will be switched to another medicine that works the same way. If you have any concerns about this, talk to your doctor .


esmolol Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor or nurse immediately if any of the following side effects occur:


More common
  • Blurred vision

  • confusion

  • dizziness, faintness, or lightheadedness when getting up from a lying or sitting position suddenly

  • increased sweating

  • unusual tiredness or weakness

Less common
  • Itching of skin

  • numbness and tingling of face, fingers, or toes

  • pain in arms, legs, or lower back, especially pain in calves and/or heels upon exertion

  • pale, bluish-colored, or cold hands or feet

  • weak or absent pulses in legs

Rare
  • Blue lips and fingernails

  • burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings

  • changes in skin color

  • changes in vision

  • chest pain or discomfort

  • convulsions

  • coughing that sometimes produces a pink frothy sputum

  • decrease in frequency of urination

  • decrease in urine volume

  • delusions

  • dementia

  • difficult, fast, noisy breathing, sometimes with wheezing

  • difficulty in passing urine (dribbling)

  • difficulty with speaking

  • feeling of warmth

  • feeling unusually cold

  • lightheadedness, dizziness, or fainting

  • loss of bladder control

  • muscle spasm or jerking of all extremities

  • no heartbeat

  • pain, tenderness, or swelling of foot or leg

  • painful urination

  • paleness of skin

  • peeling of skin

  • redness of the face, neck, arms and occasionally, upper chest

  • shivering

  • shortness of breath

  • slow or irregular heartbeat

  • small clicking, bubbling, or rattling sounds in the lung when listening with a stethoscope

  • sudden loss of consciousness

  • swelling, redness, or burning of skin where the needle is placed

  • tightness in chest

Get emergency help immediately if any of the following symptoms of overdose occur:


Symptoms of overdose
  • Dilated neck veins

  • extreme fatigue

  • irregular breathing

  • no blood pressure or pulse

  • stopping of heart

  • swelling of face, fingers, feet, or lower legs

  • unconsciousness

  • weight gain

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


More common
  • Hardening or thickening of skin where the needle is placed

  • nausea

Less common
  • Anxiety

  • dry mouth

  • headache

  • hyperventilation

  • irritability

  • nervousness

  • restlessness

  • shaking

  • sleepiness or unusual drowsiness

  • trouble sleeping

  • vomiting

Rare
  • Acid or sour stomach

  • belching

  • change in taste or bad, unusual, or unpleasant (after) taste

  • difficulty having a bowel movement (stool)

  • discouragement

  • feeling sad or empty

  • heartburn

  • indigestion

  • lack of appetite

  • lack or loss of strength

  • loss of interest or pleasure

  • shoulder pain

  • stomach soreness, discomfort, upset, or pain

  • stuffy nose

  • tiredness

  • trouble concentrating

  • weight loss

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: esmolol Intravenous side effects (in more detail)



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More esmolol Intravenous resources


  • Esmolol Intravenous Side Effects (in more detail)
  • Esmolol Intravenous Use in Pregnancy & Breastfeeding
  • Esmolol Intravenous Drug Interactions
  • Esmolol Intravenous Support Group
  • 0 Reviews for Esmolol Intravenous - Add your own review/rating


Compare esmolol Intravenous with other medications


  • Atrial Fibrillation
  • Atrial Flutter
  • Intra- or Post-op SVT or Hypertension
  • Supraventricular Tachycardia

edrophonium


Generic Name: edrophonium (ED roe FOE nee um)

Brand names: Enlon, Tensilon, Reversol


What is edrophonium?

Edrophonium is used as part of a medical test to help diagnose a muscle disorder called myasthenia gravis.


Edrophonium is sometimes used to reverse the effects of certain medications used to prevent muscle contractions during surgical procedures.


Edrophonium may also be used for other purposes not listed in this medication guide.


What is the most important information I should know about edrophonium?


You should not receive this medication if you are allergic to edrophonium, or have a blockage in your intestines or obstructed urine flow.

Before you receive edrophonium, tell your doctor if you have asthma, a heart rhythm disorder, or if you are allergic to sulfites. Also tell your doctor if you are pregnant or breast-feeding.


Tell your caregivers at once if you have a serious side effect such as slow heart rate, chest pain, weak pulse, fainting, weak or shallow breathing, increased urination, seizures, or trouble swallowing.

Less serious side effects may occur (some of which can be expected as part of a positive test reaction to edrophonium) such as watery eyes, vision problems, changes in your voice, mild nausea, vomiting, stomach pain, weakness, or muscle twitching.


What should I discuss with my health care provider before receiving edrophonium?


You should not receive this medication if you are allergic to edrophonium, or have certain conditions. Be sure your doctor knows if you have:

  • a blockage in your intestines; or




  • obstructed urine flow.



Before you receive edrophonium, tell your doctor if you are allergic to any drugs, or if you have:



  • asthma;




  • a heart rhythm disorder; or




  • if you are allergic to sulfites.



If you have any of these conditions, you may need a dose adjustment or special tests to safely receive edrophonium.


This medication may be harmful to an unborn baby. Tell your doctor if you are pregnant before you receive edrophonium. Do not receive this medication without telling your doctor if you are breast-feeding a baby.

How is edrophonium given?


Edrophonium is given as an injection through a needle placed into a muscle or vein. You will receive this injection in a clinic or hospital setting as part of a medical test.


When used in diagnosing myasthenia gravis, edrophonium is given in small doses over 15 to 45 seconds. After each dose you will be observed for the expected reaction to this medication (muscle twitching, vision changes, increased muscle weakness, sweating, stomach cramps, nausea, and other symptoms). You may receive other medications to treat the reaction to edrophonium.


The test you are receiving may be repeated a second time.


Your specific edrophonium test may be performed in a different manner than described above.


What happens if I miss a dose?


Since edrophonium is given by a healthcare professional, it is not likely that you will miss a dose.


What happens if I overdose?


Tell your caregivers right away if you think you have received too much of this medicine.

Overdose symptoms may include nausea, vomiting, diarrhea, sweating, slow heart rate, and increased salivation (drooling).


What should I avoid after receiving edrophonium?


Follow your doctor's instructions about any restrictions on food, beverages, or activity after you have been treated with edrophonium.


Edrophonium side effects


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Tell your caregivers at once if you have a serious side effect such as:

  • slow heart rate;




  • chest pain, weak pulse, increased sweating, and dizziness;




  • feeling like you might pass out;




  • weak or shallow breathing;




  • urinating more than usual;




  • seizures (convulsions); or




  • trouble swallowing.



Less serious side effects (some of which can be expected as part of a positive test reaction) may include:



  • watery eyes, vision problems;




  • changes in your voice;




  • mild nausea, vomiting, diarrhea, stomach pain;




  • weakness; or




  • muscle twitching.



This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.


What other drugs will affect edrophonium?


There may be other drugs that can interact with edrophonium. Tell your doctor about all your prescription and over-the-counter medications, vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start a new medication without telling your doctor.



More edrophonium resources


  • Edrophonium Drug Interactions
  • Edrophonium Support Group
  • 0 Reviews for Edrophonium - Add your own review/rating


  • Enlon Prescribing Information (FDA)



Compare edrophonium with other medications


  • Reversal of Nondepolarizing Muscle Relaxants


Where can I get more information?


  • Your doctor or pharmacist can provide more information about edrophonium.